Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminary safety results

Seminars in Oncology

Volumn 28, Issue 1 SUPPL. 1, 2001, Pages 35-40

  André, Thierry ^a   Colin, Philippe ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Louvet, Christophe ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Gamelin, Erick ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Bouche, Olivier ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Achille, Emmanuel ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Colbert, Nicolas ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Boaziz, Catherine ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Piedbois, Pascal ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Tubiana Mathieu, Nicole ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Boutan Laroze, Arnaud ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Flesch, Michel ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Billiau, Véronique ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}   Buyse, Marc ^{a,b,c,d,e,f,g,h,i,j,k,l,m,n,o}  

^a HÔPITAL TENON   (France)

^b From Clinique Courlancy   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d CENTRE PAUL PAPIN   (France)

^e REIMS UNIVERSITY HOSPITAL   (France)

^f Clinique de l'Orangerie Strasbourg   (France)

^g SAINT JOSEPH HOSPITAL   (France)

^h Centre d'Imagerie Paris Nord   (France)

ⁱ HENRI MONDOR HOSPITAL   (France)

^j LIMOGES UNIVERSITY HOSPITAL   (France)

^k CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^l Dijon France   (France)

^m INTERNATIONAL DRUG DEVELOPMENT INSTITUTE   (Belgium)

ⁿ From International Institute for Drug Development   (Belgium)

^o Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER SURGERY; CLINICAL TRIAL; COLON ADENOCARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTUM CARCINOMA;

EID: 0035101693     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0093-7754(01)90250-7     Document Type: Article

References (22)

1. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate
2. 5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: A randomized comparison. A Southwest Oncology Group Study
3. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma
4. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: A prospective randomized phase III trial. Gastrointestinal Tumor Study Group
5. Biochemical modulation of fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma
6. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer
7. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid
8. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study
9. Fluorouracil, leucovorin and levamisole adjuvant therapy for colon cancer: Four-year results of INT-0089
10. A prospective evaluation of chemotherapy duration and regimen as surgical adjuvant treatment of high-risk colon cancer: A collaborative trial of the NCCTG and NCICCTG
11. End results of a multicentric randomized trial comparing 5-FU in continuous systemic infusion (CI) to bolus administration (B) in measurable metastatic colorectal cancer
12. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A Mid-Atlantic Oncology Program Study
13. Phase II study of fluorouracil and its modulation in advanced colorectal cancer: A Southwest Oncology Group study
14. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer
15. Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from National Surgical Adjuvant Breast and Bowel Project C-04
16. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer
17. Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the I-isomer of intravenous leucovorin, oral leucovorin or intravenous leucovorin for the treatment of advanced colorectal cancer
18. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer
19. Comparison of fluorouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: A randomised trial
20. Multicentre randomized trial of protracted venous infusion (PVI) 5 FU compared to 5 FU/folinic acid (5-FU/AF) as adjuvant therapy for colorectal cancer
21. Phase III randomized trial of bolus 5-FU/leucovorin/levamisole versus continuous infusion/levamisole as adjuvant therapy for high risk colon cancer (SWOG 941/INT-0153)
22. Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05